Skip to main content
. 2024 Mar 9;13(3):581–595. doi: 10.1007/s40121-024-00940-3

Table 2.

Comparison of antimicrobial resistance between E. coli and K. pneumoniae uncomplicated APNs

E. coli (n = 372), N (%) K. pneumoniae (n = 125), N (%) p value
Amikacin 1 (0.3%) 2 (1.6%) 0.155
Amoxicillin/clavulanate 72 (29.1%) 17 (22.6%) 0.147
Aztreonam 127 (34.3%) 39 (31.7%) 0.005
Cefazolin 190 (51.2%) 55 (44.7%) 0.171
Cefepime 128 (34.5%) 39 (31.7%) 0.547
Cefoxitin 27 (6.0%) 4 (3.3%) 0.257
Ceftazidime 127 (34.2%) 41 (33.3%) 0.855
Ciprofloxacin 162 (43.7%) 41 (33.3%) 0.034
Ertapenem 0 (0.0%) 4 (3.3%) 0.004*
Gentamicin 111 (29.9%) 27 (21.9%) 0.075
Imipenem 0 (0.0%) 4 (3.3%) 0.004*
Piperacillin/tazobactam 19 (5.1%) 19 (15.4%)  < 0.001
TMP/SMX 151 (40.7%) 40 (32.5%) 0.106
ESBL 127 (34.2%) 35 (28.5%) 0.237

*Fisher’s exact test

TMP/SMX trimethoprim/sulfamethoxazole, ESBL extended-spectrum beta-lactamase